{"id":"W2974260792","doi":"10.1056/nejmoa1911303","title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6873,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Montreal Heart Institute; Libin Cardiovascular Institute of Alberta; St. Michael's Hospital; University of Calgary","funders":"AstraZeneca","keywords":"Dapagliflozin; Ejection fraction; Heart failure; Cardiology; Internal medicine; Fraction (chemistry); Medicine; Chemistry; Diabetes mellitus; Endocrinology; Chromatography","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}